Chemed Corporation
CHE
$534.91
$0.030.01%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.60B | 2.54B | 2.53B | 2.53B | 2.51B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.60B | 2.54B | 2.53B | 2.53B | 2.51B |
| Cost of Revenue | 1.74B | 1.72B | 1.71B | 1.70B | 1.67B |
| Gross Profit | 859.31M | 822.54M | 823.18M | 832.13M | 845.22M |
| SG&A Expenses | 438.10M | 423.22M | 414.49M | 415.94M | 412.14M |
| Depreciation & Amortization | 66.42M | 65.70M | 64.84M | 64.34M | 63.81M |
| Other Operating Expenses | -7.00K | -59.00K | 0.00 | -63.00K | -52.00K |
| Total Operating Expenses | 2.24B | 2.21B | 2.19B | 2.18B | 2.14B |
| Operating Income | 354.80M | 333.68M | 343.86M | 351.92M | 369.32M |
| Income Before Tax | 369.16M | 348.94M | 355.78M | 370.46M | 387.94M |
| Income Tax Expenses | 94.17M | 89.16M | 90.54M | 91.65M | 97.60M |
| Earnings from Continuing Operations | 274.99 | 259.78 | 265.24 | 278.81 | 290.35 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 274.99M | 259.78M | 265.24M | 278.81M | 290.35M |
| EBIT | 354.80M | 333.68M | 343.86M | 351.92M | 369.32M |
| EBITDA | 416.92M | 395.07M | 404.40M | 411.96M | 428.83M |
| EPS Basic | 19.93 | 18.39 | 18.45 | 19.05 | 19.63 |
| Normalized Basic EPS | 16.98 | 15.69 | 15.72 | 15.84 | 16.41 |
| EPS Diluted | 19.91 | 18.35 | 18.37 | 18.92 | 19.46 |
| Normalized Diluted EPS | 16.96 | 15.66 | 15.65 | 15.72 | 16.26 |
| Average Basic Shares Outstanding | 55.24M | 56.65M | 57.60M | 58.46M | 59.09M |
| Average Diluted Shares Outstanding | 55.31M | 56.81M | 57.89M | 58.87M | 59.63M |
| Dividend Per Share | 2.40 | 2.30 | 2.20 | 2.10 | 2.00 |
| Payout Ratio | 12.07% | 12.53% | 11.95% | 11.01% | 10.17% |